Results 11 to 20 of about 488,525 (347)

T helper cell subsets specific for pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis [PDF]

open access: yes, 2014
Background: We set out to determine the magnitude of antigen-specific memory T helper cell responses to Pseudomonas aeruginosa in healthy humans and patients with cystic fibrosis.
AJ Vallis   +36 more
core   +11 more sources

In vitro and in vivo screening for novel essential cell-envelope proteins in Pseudomonas aeruginosa [PDF]

open access: yes, 2015
The Gram-negative bacterium Pseudomonas aeruginosa represents a prototype of multi-drug resistant opportunistic pathogens for which novel therapeutic options are urgently required.
Bragonzi, Alessandra   +5 more
core   +1 more source

Pyoverdine and proteases affect the response of pseudomonas aeruginosa to gallium in human serum [PDF]

open access: yes, 2015
Gallium is an iron mimetic which has recently been repurposed as an antibacterial agent due to its capability to disrupt bacterial iron metabolism. In this study, the antibacterial activity of gallium nitrate [Ga(NO3)3] was investigated in complement ...
Bonchi, Carlo   +3 more
core   +1 more source

Integrative omics analysis of Pseudomonas aeruginosa virus PA5oct highlights the molecular complexity of jumbo phages [PDF]

open access: yes, 2020
Pseudomonas virus vB_PaeM_PA5oct is proposed as a model jumbo bacteriophage to investigate phage-bacteria interactions and is a candidate for phage therapy applications.
Blasdel, Bob G.   +9 more
core   +1 more source

The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa [PDF]

open access: yes, 2006
Certain members of the fluorescent pseudomonads produce and secrete phenazines. These heterocyclic, redox-active compounds are toxic to competing organisms, and the cause of these antibiotic effects has been the focus of intense research efforts.
Dietrich, Lars E. P.   +4 more
core   +1 more source

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms [PDF]

open access: yes, 2019
Gram-negative (GN) rods cause about 10% periprosthetic joint infection (PJI) and represent an increasing challenge due to emergence of antimicrobial resistance.
Di Luca, Mariagrazia   +4 more
core   +1 more source

Maintenance of Microbial Cooperation Mediated by Public Goods in Single- and Multiple-Trait Scenarios [PDF]

open access: yes, 2017
Microbes often form densely populated communities, which favor competitive and cooperative interactions. Cooperation among bacteria often occurs through the production of metabolically costly molecules produced by certain individuals that become ...
Balbontín, Roberto   +3 more
core   +1 more source

Studies on Pseudomonas aeruginosa

open access: yesNippon Saikingaku Zasshi, 1962
Recent trend of popular application of antibiotics has resulted suppression of incidence of pathogenicorganisms in many cases which were often replaced by Ps. aeruginosa because of its in difference from theseantibiotics. Authors report the results of investigations carried on biochemical and serological characteristicson this species and additionally ...
T, HORIKAWA   +4 more
openaire   +3 more sources

Characterization of CMR5c and CMR12a, novel fluorescent Pseudomonas strains from the cocoyam rhizosphere with biocontrol activity [PDF]

open access: yes, 2007
Aim: To screen for novel antagonistic Pseudomonas strains producing both phenazines and biosurfactants that are as effective as Pseudomonas aeruginosa PNA1 in the biocontrol of cocoyam root rot caused by Pythium myriotylum.
Adiobo, Amayana   +6 more
core   +2 more sources

Pseudomonas aeruginosa [PDF]

open access: yesInternational Journal of Infectious Diseases, 2010
Abstract Pseudomonas aeruginosa is a highly versatile environmental Gram-negative bacterium that can be isolated from a wide range of habitats, including soil, marshes, and the ocean, as well as from plant and animal tissues. It is resistant to many disinfectants and antibiotics, giving it a selective advantage in hospitals.
G.C.K.W. Koh, S.J. Peacock
  +4 more sources

Home - About - Disclaimer - Privacy